EINDHOVEN,
Key Highlights for the Third Quarter 2026:
Summary of Reported Third Quarter 2026 ($ millions, unaudited) (1)
| Q3 2026 | Q2 2026 | Q3 2025 | Q - Q | Y - Y | |||||||
| Total Revenue | $ | 3,786 | $ | 3,496 | $ | 3,173 | 8% | 19% | |||
| GAAP Gross Profit | $ | 2,189 | $ | 2,002 | $ | 1,787 | 9% | 22% | |||
| Gross Profit Adjustments(i) | $ | (28 | ) | $ | (26 | ) | $ | (23 | ) | ||
| Non-GAAP Gross Profit | $ | 2,217 | $ | 2,028 | $ | 1,810 | 9% | 22% | |||
| GAAP Gross Margin | 57.8 | % | 57.3 | % | 56.3 | % | |||||
| Non-GAAP Gross Margin | 58.6 | % | 58.0 | % | 57.0 | % | |||||
| GAAP Operating Income (Loss) | $ | 1,228 | $ | 1,071 | $ | 893 | 15% | 38% | |||
| Operating Income Adjustments(i) | $ | (178 | ) | $ | (157 | ) | $ | (178 | ) | ||
| Non-GAAP Operating Income | $ | 1,406 | $ | 1,228 | $ | 1,071 | 14% | 31% | |||
| GAAP Operating Margin | 32.4 | % | 30.6 | % | 28.1 | % | |||||
| Non-GAAP Operating Margin | 37.1 | % | 35.1 | % | 33.8 | % | |||||
| GAAP Net Income (Loss) attributable to Stockholders | $ | 884 | $ | 767 | $ | 631 | 15% | 40% | |||
| Net Income Adjustments(i) | $ | (181 | ) | $ | (151 | ) | $ | (159 | ) | ||
| Non-GAAP Net Income (Loss) Attributable to Stockholders | $ | 1,065 | $ | 918 | $ | 790 | 16% | 35% | |||
| GAAP diluted Net Income (Loss) per Share(ii) | $ | 3.48 | $ | 3.02 | $ | 2.48 | 15% | 40% | |||
| Non-GAAP diluted Net Income (Loss) per Share(ii) | $ | 4.20 | $ | 3.61 | $ | 3.11 | 16% | 35% | |||
| Additional information | |||||||||||
| Q3 2026 |
Q2 2026 |
Q3 2025 |
Q - Q | Y - Y | |||||||
| Automotive | $ | 2,070 | $ | 1,938 | $ | 1,837 | 7% | 13% | |||
| Industrial & IoT | $ | 802 | $ | 755 | $ | 579 | 6% | 39% | |||
| Mobile | $ | 411 | $ | 351 | $ | 430 | 17% | -4% | |||
| Comm. Infra. & Other | $ | 503 | $ | 452 | $ | 327 | 11% | 54% | |||
| DIO | 148 | 156 | 161 | ||||||||
| DPO | 62 | 60 | 58 | ||||||||
| DSO | 30 | 33 | 31 | ||||||||
| Cash Conversion Cycle | 116 | 129 | 134 | ||||||||
| Channel Inventory (weeks) | 11 | 11 | 9 | ||||||||
| Gross Financial Leverage(iii) | 2.0x | 2.1x | 2.6x | ||||||||
| Net Financial Leverage(iv) | 1.3x | 1.5x | 1.8x | ||||||||
Guidance for the Fourth Quarter 2026: ($ millions, except Per Share data) (1)
| GAAP | Reconciliation | non-GAAP | ||||||||||||
| Low | Mid | High | Low | Mid | High | |||||||||
| Total Revenue | $3,750 | $3,850 | $3,950 | $3,750 | $3,850 | $3,950 | ||||||||
| Q-Q | -1% | 2% | 4% | -1% | 2% | 4% | ||||||||
| Y-Y | 12% | 15% | 18% | 12% | 15% | 18% | ||||||||
| Gross Profit | $2,160 | $2,238 | $2,317 | $2,195 | $2,273 | $2,352 | ||||||||
| Gross Margin | 57.6% | 58.1% | 58.7% | 58.5% | 59.0% | 59.5% | ||||||||
| Operating Income (loss) | $1,167 | $1,235 | $1,304 | $1,374 | $1,442 | $1,511 | ||||||||
| Operating Margin | 31.1% | 32.1% | 33.0% | 36.6% | 37.5% | 38.3% | ||||||||
| Financial Income (expense) | ||||||||||||||
| Tax rate | 18.6%-19.6% | 17.0%-18.0% | ||||||||||||
| Equity-accounted investees | ||||||||||||||
| Non-controlling interests | ||||||||||||||
| Shares - diluted | 253.8 | 253.8 | 253.8 | 253.8 | 253.8 | 253.8 | ||||||||
| Earnings Per Share - diluted | $3.36 | $3.57 | $3.79 | $4.14 | $4.36 | $4.58 | ||||||||
Note (1) Additional Information:
Non-GAAP Financial Measures
In managing
These non-GAAP financial measures are provided in addition to, and not as a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. The presentation of these and other similar items in NXP’s non-GAAP financial results should not be interpreted as implying that these items are non-recurring, infrequent, or unusual. Reconciliations of these non-GAAP measures to the most comparable measures calculated in accordance with GAAP are provided in the financial statements portion of this release in a schedule entitled “Financial Reconciliation of GAAP to non-GAAP Results (unaudited).” Please refer to the
In addition to providing financial information on a basis consistent with GAAP,
The difference in the benefit (provision) for income taxes between our GAAP and non-GAAP results relates to the income tax effects of the GAAP to non-GAAP adjustments that we make and the income tax effect of any discrete items that occur in the interim period. Discrete items primarily relate to unexpected tax events that may occur as these amounts cannot be forecasted (e.g., the impact of changes in tax law and/or rates, changes in estimates or resolved tax audits relating to prior year tax provisions, the excess or deficit tax effects on share-based compensation, etc.).
Conference Call and Webcast Information
The company will host a conference call with the financial community on
Interested parties may preregister to obtain a user-specific access code for the call here.
The call will be webcast and can be accessed from the
About
Forward-looking Statements
This document includes forward-looking statements which include statements regarding NXP’s business strategy, financial condition, results of operations, market data, as well as any other statements which are not historical facts. By their nature, forward-looking statements are subject to numerous factors, risks and uncertainties that could cause actual outcomes and results to be materially different from those projected. These factors, risks and uncertainties include the following: market demand and semiconductor industry conditions; our ability to successfully introduce new technologies and products; the demand for the goods into which our products are incorporated; recent changes in global trade policy including tariffs and related trade actions announced by the
For further information, please contact:
| Investors: | Media: | |
| jeff.palmer@nxp.com | paige.iven@nxp.com | |
| +1 408 205 0687 | +1 817 975 0602 | |
| mike.lucarelli@nxp.com | ||
| +1 617 943 6892 | ||
Table 1: Condensed consolidated statement of operations (unaudited)
| ($ in millions except share data) | Three months ended | ||||||||||
| September 27, 2026 |
September 28, 2025 |
||||||||||
| Revenue | $ | 3,786 | $ | 3,496 | $ | 3,173 | |||||
| Cost of revenue | (1,597 | ) | (1,494 | ) | (1,386 | ) | |||||
| Gross profit | 2,189 | 2,002 | 1,787 | ||||||||
| Research and development | (615 | ) | (604 | ) | (575 | ) | |||||
| Selling, general and administrative | (313 | ) | (291 | ) | (286 | ) | |||||
| Amortization of acquisition-related intangible assets | (30 | ) | (31 | ) | (31 | ) | |||||
| Total operating expenses | (958 | ) | (926 | ) | (892 | ) | |||||
| Other income (expense) | (3 | ) | (5 | ) | (2 | ) | |||||
| Operating income (loss) | 1,228 | 1,071 | 893 | ||||||||
| Financial income (expense): | |||||||||||
| Other financial income (expense) | (97 | ) | (97 | ) | (98 | ) | |||||
| Income (loss) before income taxes | 1,131 | 974 | 795 | ||||||||
| Benefit (provision) for income taxes | (228 | ) | (189 | ) | (148 | ) | |||||
| Results relating to equity-accounted investees | (4 | ) | (3 | ) | (1 | ) | |||||
| Net income (loss) | 899 | 782 | 646 | ||||||||
| Less: Net income (loss) attributable to non-controlling interests | 15 | 15 | 15 | ||||||||
| Net income (loss) attributable to stockholders | 884 | 767 | 631 | ||||||||
| Earnings per share data: | |||||||||||
| Net income (loss) per common share attributable to stockholders in $ | |||||||||||
| Basic | $ | 3.51 | $ | 3.04 | $ | 2.50 | |||||
| Diluted | $ | 3.48 | $ | 3.02 | $ | 2.48 | |||||
| Weighted average number of shares of common stock outstanding during the period (in thousands): | |||||||||||
| Basic | 252,123 | 252,415 | 252,170 | ||||||||
| Diluted | 253,831 | 254,021 | 254,310 | ||||||||
Table 2: Condensed consolidated balance sheet (unaudited)
| ($ in millions) | As of | ||||||||
| September 27, 2026 |
September 28, 2025 |
||||||||
| ASSETS | |||||||||
| Current assets: | |||||||||
| Cash and cash equivalents | $ | 3,943 | $ | 3,222 | $ | 3,454 | |||
| Short-term deposits | — | — | 500 | ||||||
| Accounts receivable, net | 1,260 | 1,274 | 1,095 | ||||||
| Assets held for sale | 92 | 92 | 292 | ||||||
| Inventories, net | 2,596 | 2,557 | 2,452 | ||||||
| Other current assets | 544 | 539 | 716 | ||||||
| Total current assets | 8,435 | 7,684 | 8,509 | ||||||
| Non-current assets: | |||||||||
| Deferred tax assets | 1,297 | 1,242 | 1,313 | ||||||
| Other non-current assets | 3,432 | 3,195 | 2,186 | ||||||
| Property, plant and equipment, net | 2,803 | 2,835 | 3,086 | ||||||
| Identified intangible assets, net | 1,381 | 1,441 | 1,139 | ||||||
| 10,259 | 10,268 | 10,121 | |||||||
| Total non-current assets | 19,172 | 18,981 | 17,845 | ||||||
| Total assets | 27,607 | 26,665 | 26,354 | ||||||
| LIABILITIES AND EQUITY | |||||||||
| Current liabilities: | |||||||||
| Accounts payable | 1,089 | 984 | 886 | ||||||
| Restructuring liabilities-current | 83 | 111 | 49 | ||||||
| Other current liabilities | 1,799 | 1,672 | 1,384 | ||||||
| Short-term debt | 999 | 999 | 1,264 | ||||||
| Total current liabilities | 3,970 | 3,766 | 3,583 | ||||||
| Non-current liabilities: | |||||||||
| Long-term debt | 9,979 | 9,977 | 10,971 | ||||||
| Restructuring liabilities | 65 | 65 | 60 | ||||||
| Other non-current liabilities | 1,128 | 1,096 | 1,313 | ||||||
| Total non-current liabilities | 11,172 | 11,138 | 12,344 | ||||||
| Non-controlling interests | 377 | 362 | 382 | ||||||
| Stockholders’ equity | 12,088 | 11,399 | 10,045 | ||||||
| Total equity | 12,465 | 11,761 | 10,427 | ||||||
| Total liabilities and equity | 27,607 | 26,665 | 26,354 | ||||||
Table 3: Condensed consolidated statement of cash flows (unaudited)
| ($ in millions) | Three months ended | ||||||||||
| September 27, 2026 |
September 28, 2025 |
||||||||||
| Cash flows from operating activities: | |||||||||||
| Net income (loss) | $ | 899 | $ | 782 | $ | 646 | |||||
| Cash flows provided by (used for) operating activities: | |||||||||||
| Depreciation and amortization | 192 | 184 | 201 | ||||||||
| Share-based compensation | 114 | 105 | 118 | ||||||||
| Amortization of discount (premium) on debt, net | 1 | — | 1 | ||||||||
| Amortization of debt issuance costs | 1 | 2 | 2 | ||||||||
| Net (gain) loss on sale of assets | — | — | (1 | ) | |||||||
| Results relating to equity-accounted investees | 4 | 3 | 1 | ||||||||
| (Gain) loss on equity securities, net | 2 | 1 | (1 | ) | |||||||
| Deferred tax expense (benefit) | (43 | ) | (13 | ) | (8 | ) | |||||
| Changes in operating assets and liabilities: | |||||||||||
| (Increase) decrease in receivables and other current assets | 11 | 14 | 54 | ||||||||
| (Increase) decrease in inventories | (39 | ) | (34 | ) | (96 | ) | |||||
| Increase (decrease) in accounts payable and other liabilities | 196 | (136 | ) | (219 | ) | ||||||
| (Increase) decrease in other non-current assets | (97 | ) | (48 | ) | (123 | ) | |||||
| Exchange differences | 11 | 3 | 8 | ||||||||
| Other items | 4 | (3 | ) | 2 | |||||||
| Net cash provided by (used for) operating activities | 1,256 | 860 | 585 | ||||||||
| Cash flows from investing activities: | |||||||||||
| Purchase of identified intangible assets | (36 | ) | (37 | ) | (23 | ) | |||||
| Capital expenditures on property, plant and equipment | (51 | ) | (69 | ) | (77 | ) | |||||
| Proceeds from the disposals of property, plant and equipment | 1 | — | 1 | ||||||||
| Purchase of interests in businesses, net of cash acquired | — | — | (11 | ) | |||||||
| Advance proceeds related to business disposition | 34 | — | — | ||||||||
| Investment in short-term deposits | 0 | — | (500 | ) | |||||||
| Purchase of investments | (124 | ) | (132 | ) | (173 | ) | |||||
| Proceeds from the sale of investments | (1 | ) | 1 | — | |||||||
| Net cash provided by (used for) investing activities | (177 | ) | (237 | ) | (783 | ) | |||||
| Cash flows from financing activities: | |||||||||||
| Repurchase of long-term debt | — | (750 | ) | — | |||||||
| Proceeds from the issuance of long-term debt | — | — | 1,498 | ||||||||
| Cash paid for debt issuance costs | — | — | (8 | ) | |||||||
| Proceeds from the issuance of commercial paper notes | — | — | 215 | ||||||||
| Repayment of commercial paper notes | — | — | (950 | ) | |||||||
| Dividends paid to non-controlling interests | (30 | ) | — | — | |||||||
| Dividends paid to common stockholders | (256 | ) | (256 | ) | (256 | ) | |||||
| Proceeds from issuance of common stock through stock plans | 34 | 1 | 38 | ||||||||
| Purchase of treasury shares and restricted stock unit withholdings | (103 | ) | (104 | ) | (54 | ) | |||||
| Other, net | — | — | (1 | ) | |||||||
| Net cash provided by (used for) financing activities | (355 | ) | (1,109 | ) | 482 | ||||||
| Effect of changes in exchange rates on cash positions | (3 | ) | — | — | |||||||
| Increase (decrease) in cash and cash equivalents | 721 | (486 | ) | 284 | |||||||
| Cash and cash equivalents at beginning of period | 3,222 | 3,708 | 3,170 | ||||||||
| Cash and cash equivalents at end of period | 3,943 | 3,222 | 3,454 | ||||||||
Table 4: Financial Reconciliation of GAAP to non-GAAP Results (unaudited)
| ($ in millions except share data) | Three months ended | ||||||||||
| September 27, 2026 |
September 28, 2025 |
||||||||||
| GAAP Gross Profit | $ | 2,189 | $ | 2,002 | $ | 1,787 | |||||
| PPA Effects | (6 | ) | (5 | ) | (6 | ) | |||||
| Restructuring | 9 | — | — | ||||||||
| Share-based compensation | (14 | ) | (12 | ) | (15 | ) | |||||
| Other incidentals | (17 | ) | (9 | ) | (2 | ) | |||||
| Non-GAAP Gross Profit | $ | 2,217 | $ | 2,028 | $ | 1,810 | |||||
| $ | (615 | ) | $ | (604 | ) | $ | (575 | ) | |||
| Restructuring | (3 | ) | 4 | (1 | ) | ||||||
| Share-based compensation | (53 | ) | (54 | ) | (57 | ) | |||||
| Other incidentals | (2 | ) | (4 | ) | (2 | ) | |||||
| $ | (557 | ) | $ | (550 | ) | $ | (515 | ) | |||
| GAAP Selling, general and administrative | $ | (313 | ) | $ | (291 | ) | $ | (286 | ) | ||
| PPA effects | — | — | (1 | ) | |||||||
| Restructuring | (1 | ) | 4 | (2 | ) | ||||||
| Share-based compensation | (47 | ) | (39 | ) | (46 | ) | |||||
| Other incidentals | (12 | ) | (12 | ) | (14 | ) | |||||
| Non-GAAP Selling, general and administrative | $ | (253 | ) | $ | (244 | ) | $ | (223 | ) | ||
| GAAP Other income (expense) | $ | (3 | ) | $ | (5 | ) | $ | (2 | ) | ||
| Other incidentals | (2 | ) | 1 | (1 | ) | ||||||
| Non-GAAP Other income (expense) | $ | (1 | ) | $ | (6 | ) | $ | (1 | ) | ||
| GAAP Operating income (loss) | $ | 1,228 | $ | 1,071 | $ | 893 | |||||
| PPA effects | (36 | ) | (36 | ) | (38 | ) | |||||
| Restructuring | 5 | 8 | (3 | ) | |||||||
| Share-based compensation | (114 | ) | (105 | ) | (118 | ) | |||||
| Other incidentals | (33 | ) | (24 | ) | (19 | ) | |||||
| Non-GAAP Operating income (loss) | $ | 1,406 | $ | 1,228 | $ | 1,071 | |||||
| GAAP Financial income (expense) | $ | (97 | ) | $ | (97 | ) | $ | (98 | ) | ||
| Foreign exchange gain (loss) | (9 | ) | (5 | ) | (6 | ) | |||||
| Other financial income (expense) | (3 | ) | (5 | ) | (1 | ) | |||||
| Non-GAAP Financial income (expense) | $ | (85 | ) | $ | (87 | ) | $ | (91 | ) | ||
| GAAP Income tax benefit (provision) | $ | (228 | ) | $ | (189 | ) | $ | (148 | ) | ||
| Income tax effect | 9 | 16 | 25 | ||||||||
| Non-GAAP Income tax benefit (provision) | $ | (237 | ) | $ | (205 | ) | $ | (173 | ) | ||
| GAAP Results relating to equity-accounted investees | $ | (4 | ) | $ | (3 | ) | $ | (1 | ) | ||
| Results relating to equity-accounted investees, excluding Foundry investees1 | — | — | 1 | ||||||||
| Non-GAAP Results relating to equity-accounted investees | $ | (4 | ) | $ | (3 | ) | $ | (2 | ) | ||
| GAAP Net income (loss) | $ | 899 | $ | 782 | $ | 646 | |||||
| Less: Net income (loss) attributable to non-controlling interest | 15 | 15 | 15 | ||||||||
| GAAP Net income (loss) attributable to stockholders | $ | 884 | $ | 767 | $ | 631 | |||||
| GAAP Net income (loss) attributable to stockholders | $ | 884 | $ | 767 | $ | 631 | |||||
| PPA Effects | (36 | ) | (36 | ) | (38 | ) | |||||
| Restructuring | 5 | 8 | (3 | ) | |||||||
| Share-based compensation | (114 | ) | (105 | ) | (118 | ) | |||||
| Other incidentals | (33 | ) | (24 | ) | (19 | ) | |||||
| Other adjustments: | |||||||||||
| Adjustments to financial income (expense) | (12 | ) | (10 | ) | (7 | ) | |||||
| Income tax effect | 9 | 16 | 25 | ||||||||
| Results relating to equity-accounted investees, excluding Foundry investees1 | — | — | 1 | ||||||||
| Non-GAAP Net income (loss) attributable to stockholders | $ | 1,065 | $ | 918 | $ | 790 | |||||
| GAAP net income (loss) per common share attributable to stockholders - diluted | $ | 3.48 | $ | 3.02 | $ | 2.48 | |||||
| PPA Effects | (0.14 | ) | (0.14 | ) | (0.15 | ) | |||||
| Restructuring | 0.02 | 0.03 | (0.01 | ) | |||||||
| Share-based compensation | (0.45 | ) | (0.41 | ) | (0.47 | ) | |||||
| Other incidentals | (0.14 | ) | (0.09 | ) | (0.08 | ) | |||||
| Other adjustments: | |||||||||||
| Adjustments to financial income (expense) | (0.05 | ) | (0.04 | ) | (0.02 | ) | |||||
| Income tax effect | 0.04 | 0.06 | 0.10 | ||||||||
| Results relating to equity-accounted investees, excluding Foundry investees1 | — | — | — | ||||||||
| Non-GAAP net income (loss) per common share attributable to stockholders - diluted | $ | 4.20 | $ | 3.61 | $ | 3.11 | |||||
| Additional Information: | |||||||||||
|
|||||||||||
Table 5: Adjusted EBITDA and Free Cash Flow (unaudited)
| ($ in millions) | Three months ended | ||||||||||
| September 27, 2026 |
September 28, 2025 |
||||||||||
| GAAP Net income (loss) | $ | 899 | $ | 782 | $ | 646 | |||||
| Reconciling items to EBITDA (Non-GAAP) | |||||||||||
| Financial (income) expense | 97 | 97 | 98 | ||||||||
| (Benefit) provision for income taxes | 228 | 189 | 148 | ||||||||
| Depreciation and impairment | 123 | 114 | 132 | ||||||||
| Amortization | 69 | 70 | 69 | ||||||||
| EBITDA (Non-GAAP) | $ | 1,416 | $ | 1,252 | $ | 1,093 | |||||
| Reconciling items to adjusted EBITDA (Non-GAAP) | |||||||||||
| Results of equity-accounted investees, excluding Foundry investees1 | — | — | (1 | ) | |||||||
| Restructuring | (5 | ) | (8 | ) | 3 | ||||||
| Share-based compensation | 114 | 105 | 118 | ||||||||
| Other incidental items2 | 22 | 20 | 19 | ||||||||
| Adjusted EBITDA (Non-GAAP) | $ | 1,547 | $ | 1,369 | $ | 1,232 | |||||
| Trailing twelve month adjusted EBITDA (Non-GAAP) | $ | 5,421 | $ | 5,106 | $ | 4,648 | |||||
| Additional Information: | |||||||||||
| 1. Refer to Table 4 above for further information regarding the results relating to equity-accounted investees. | |||||||||||
| 2. Excluding depreciation and impairment or amortization relating to: | |||||||||||
| – other incidental items | 11 | 4 | — | ||||||||
| ($ in millions) | Three months ended | ||||||||||
| September 27, 2026 |
September 28, 2025 |
||||||||||
| Net cash provided by (used for) operating activities | $ | 1,256 | $ | 860 | $ | 585 | |||||
| Net capital expenditures on property, plant and equipment | (50 | ) | (69 | ) | (76 | ) | |||||
| Non-GAAP free cash flow | $ | 1,206 | $ | 791 | $ | 509 | |||||
| Trailing twelve month non-GAAP free cash flow | $ | 3,504 | $ | 2,807 | $ | 1,924 | |||||
| Trailing twelve month non-GAAP free cash flow as percent of Revenue |
25 | % | 21 | % | 16 | % | |||||
Source: NXP USA, Inc.